The authors analyzed 4708 adult acute myeloid leukemia patients recruited into Study Alliance Leukemia trials to investigate the prognostic impact of CEBPAsm.
[Blood]
7992332
{7992332:J5TBW3JL}
apa
50
1
165179
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/